Plus Therapeutics to Showcase Breakthroughs in CNS Cancer Treatments at SNO/ASCO 2024 Conference
Plus Therapeutics, a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, will have multiple opportunities to present data at the… read more.